Shahid Mallick, MD
Pulmonary Disease · Sugar Land, TXNPI 1396738415
Payments from drug & device makers
Across 8 payments — averaging $13.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$45
- CSL Behring$41
- Itamar Medical Inc$13
- United Therapeutics Corporation$10
What the payments were for
- Food & beverage$1312%
- Education$9688%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 1 | $45 |
| CSL Behring | 2 | $41 |
| Itamar Medical Inc | 1 | $13 |
| United Therapeutics Corporation | 4 | $10 |
How this compares
$110 in reported general payments places this provider in the 10th percentile of 904 pulmonary disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 42 | $522,331 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 426 | $312,430 |
| OpsumitMacitentan | 11 | $231,922 |
| Breo ElliptaFluticasone/Vilanterol | 168 | $88,487 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 90 | $66,401 |
| Dupixent PenDupilumab | 13 | $57,550 |
| Spiriva RespimatTiotropium Bromide | 58 | $35,599 |
| Spiriva HandihalerTiotropium Bromide | 49 | $29,946 |
| SymbicortBudesonide/Formoterol Fumarate | 76 | $26,361 |
| Incruse ElliptaUmeclidinium Bromide | 51 | $20,915 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 95 | $14,228 |
| Roflumilast | 109 | $13,233 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 27 | $11,275 |
| Arnuity ElliptaFluticasone Furoate | 24 | $8,204 |
| Advair HfaFluticasone Propion/Salmeterol | 23 | $7,770 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Sugar Land
- Charles AndrewsSan Antonio$17M
- Ivan RosasHouston$13.8M
- Shahrukh KureishyMcKinney$12.4M
- Raksha JainDallas$3.4M
- Kelly ChinDallas$2.7M
- Julie PhilleyTyler$2.4M
- Nicola HananiaHouston$2.2M
- Sandeep SahayHouston$2.1M
- Antonio AnzuetoSan Antonio$1.8M
- Diego Maselli CaceresSan Antonio$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.